Our results demonstrated that the plasma Gas6 levels were significantly lower in advanced coronary artery disease patients undergoing CABG than in control subjects and that plasma Gas6 levels were negatively correlated with fasting glucose, E-selectin, and VCAM-1 levels. This evidence concerns the gene SELE and coronary artery disorder.